Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors

Figure 2

Glimmix model estimated percent survivorship of An. gambiae s.s. grouped by treatment and phase. Glimmix model estimated percent survivorship of all An. gambiae s.s. (N = 1265) held five days post-capture from all three replicates. * Treatment by phase was significant (F-value = 18.27, P < 0.0001). Treatment at phase 2 significantly differed from control at phase 2 (t-value = 4.01, P = 0.0003), treatment at phase 1 (t-value = 8.31, P < 0.0001), and treatment at phase 3 (t-value = -4.61, P < 0.0001).

Back to article page